Loading...
Last submissions
-
-
Hugo Herrscher, Maud Bronnec, Delphine Antoni, Jean-Pierre Ghnassia, Pascale Magnenet, et al.. Successful treatment of primary cutaneous angiosarcoma of the nose with sequential chemo- and radiotherapy. Clinical and Translational Radiation Oncology, 2019, 21, pp.1-4. ⟨10.1016/j.ctro.2019.11.001⟩. ⟨hal-04303939⟩
-
Thomas Grinda, Alison Antoine, William Jacot, Paul-Henri Cottu, Thibault de la Motte Rouge, et al.. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. European Journal of Cancer, 2023, 189, pp.112935. ⟨10.1016/j.ejca.2023.05.023⟩. ⟨hal-04205902⟩
-
Alexandre Bertucci, F. Bertucci, Christophe Zemmour, Florence Lerebours, Jean-Yves Pierga, et al.. PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer. Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.575978⟩. ⟨hal-03623650⟩
-
-
Véronique Vendrely, Philippe Ronchin, Mathieu Minsat, Karine Le Malicot, Claire Lemanski, et al.. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial. Radiotherapy & Oncology, 2023, 186, pp.109742. ⟨10.1016/j.radonc.2023.109742⟩. ⟨hal-04163679⟩
-
D. Dano, A. Lardy-Cleaud, A. Monneur, N. Quenel-Tueux, C. Levy, et al.. Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME). ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩. ⟨hal-03426433⟩
-
-
-
Cédric Hemon, Bastien Rigaud, Anais Barateau, Florian Tilquin, Vincent Noblet, et al.. Contour-guided deep learning based deformable image registration for dose monitoring during CBCT-guided radiotherapy of prostate cancer. Journal of Applied Clinical Medical Physics, 2023, pp.e13991. ⟨10.1002/acm2.13991⟩. ⟨hal-04112657⟩
-
Francois-Xavier Danlos, Matthieu Texier, Bastien Job, Severine Mouraud, Lydie Cassard, et al.. Genomic Instability and Pro-Tumoral Inflammation are associated with Primary Resistance to Anti-PD1 + Anti-Angiogenesis in Malignant Pleural Mesothelioma. Cancer Discovery, 2023, pp.OF1-OF22. ⟨10.1158/2159-8290.CD-22-0886⟩. ⟨hal-03972355⟩
-
Jean-Frédéric Blanc, Faiza Khemissa, Jean-Pierre Bronowicki, Carole Monterymard, Jean-Marc Perarnau, et al.. Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis. Hepatology international, 2021, 15 (1), pp.93-104. ⟨10.1007/s12072-020-10120-3⟩. ⟨hal-03881843⟩
-
C. Xhaard, A. Dumas, V. Souchard, Y. Ren, F. Borson-Chazot, et al.. Are dietary reports in a case-control study on thyroid cancer biased by risk perception of Chernobyl fallout?. Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2017, 65 (4), pp.301-308. ⟨10.1016/j.respe.2017.02.002⟩. ⟨hal-04043710⟩
-
Thomas Raze, Brigitte Lacour, Anne Cowppli-Bony, Patricia Delafosse, Michel Velten, et al.. Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival. Journal of Adolescent and Young Adult Oncology, 2021, 10 (1), pp.29-45. ⟨10.1089/jayao.2020.0017⟩. ⟨hal-04020187⟩
-
-
-
Christian Borel, Olivier Regnier-Gavier, Hélène Carinato, Sébastien Guihard, Delphine Antoni, et al.. Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget, 2018, 9 (101), pp.37581-37588. ⟨10.18632/oncotarget.26506⟩. ⟨hal-03881981⟩
-
-
Alexandre Detappe, Clélia Mathieu, Caining Jin, Michael P. Agius, Marie-Charlotte Deringer, et al.. Anti-MUC1-C Antibody–Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 2020, 108 (5), pp.1380-1389. ⟨10.1016/j.ijrobp.2020.06.069⟩. ⟨hal-03093629⟩
-
Waisse Waissi, Anaïs Nicol, Matthieu Jung, Marc Rousseau, Delphine Jarnet, et al.. Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation. Cancers, 2021, 13 (3), pp.527. ⟨10.3390/cancers13030527⟩. ⟨hal-03160783⟩